(Q36565152)

15 August 2017

1 reference

title

Past, imminent and future human medical countermeasures for anthrax (English)

1 reference

15 August 2017

Baillie LW

1

1 reference

15 August 2017

language of work or name

1 reference

1 September 2006

1 reference

Journal of Applied Microbiology

15 August 2017

published in

1 reference

15 August 2017

volume

101

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

594-606

1 reference

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Selection of Bacillus anthracis isolates resistant to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The development of new vaccines against Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Bacillus anthracis, a bug with attitude!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Characterisation of the immune response to the UK human anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Characterization of the human immune response to the UK anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Role of superoxide in the germination of Bacillus anthracis endospores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Passive transfer of protection against Bacillus anthracis infection in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Typhoid and paratyphoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Identification of the cellular receptor for anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Passive antibody administration (immediate immunity) as a specific defense against biological weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Serum protease cleavage of Bacillus anthracis protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The capsule of bacillus anthracis, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Bacillus anthracis surface: capsule and S-layer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

DNA vaccines against anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Salmonella vaccines for use in humans: present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Fate of germinated Bacillus anthracis spores in primary murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Germination of Bacillus anthracis spores within alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Understanding Bacillus anthracis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Murine macrophages kill the vegetative form of Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Induction of protective immunity against lethal anthrax challenge with a patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Molecular pathogenesis of Bacillus anthracis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Formation and composition of the Bacillus anthracis endospore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The roles of anthrax toxin in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Crystal structure of the anthrax toxin protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Population structure and evolution of the Bacillus cereus group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Importance of nitric oxide synthase in the control of infection by Bacillus anthracis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Antitoxins: novel strategies to target agents of bioterrorism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Identification of proteins in the exosporium of Bacillus anthracis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Development of novel vaccines against anthrax in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Sowing the seeds of success: pharmaceutical proteins from plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Lipopolysaccharide releases a priming substance from platelets that augments the oxidative response of polymorphonuclear neutrophils to chemotactic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Iraq's biological weapons. The past as future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

Microarray-based resequencing of multiple Bacillus anthracis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03112.X

10.1111/J.1365-2672.2006.03112.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference